Regeneron Pharmaceuticals, Inc.

REGN
$804.29 (- $14.80 - 1.81%)
Last updated: 2026-10-23 14:18 UTC
REGN Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS75886F1075
CUSIP75886F107
Market Price804.29
Dividend Yield 0.47%
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend 3.70
Latest Payout ($)0.94
Latest Payout Date2026-08-31
Dividend FrequencyQuarterly
P/E Ratio18.6
EPS41.69
Market Cap$83.1B
Book Value301.15
Price to Book2.602
Beta-0.54
52w High859.34
52w Low541.0
Next Earnings Date2026-10-30

Regeneron Pharmaceuticals, Inc. trades under ticker REGN on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US75886F1075, CUSIP 75886F107. Also searched as Regeneron Pharmaceuticals.

Related researchREGN stock priceREGN share priceREGN dividend historyREGN dividend yieldRegeneron Pharmaceuticals dividend historyRegeneron Pharmaceuticals dividend yield75886F107Regeneron Pharmaceuticals stockRegeneron Pharmaceuticals share price
About the Company
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, develops, manufactures, and commercializes medicines for people with serious diseases. Its portfolio spans treatments in eye care, immunology, oncology, cardiovascular and metabolic disease, infectious disease, hematology, and rare disorders. The company is known for combining laboratory research, clinical development, and in-house manufacturing to advance biologic therapies and antibody-based medicines. Regeneron also works on product candidates across multiple therapeutic areas, supporting a broad drug pipeline alongside its marketed medicines. Regeneron Pharmaceuticals, Inc. plays an important role in the healthcare market through its focus on specialty therapies designed for complex and often chronic medical conditions.
Price History